GlaxoSmithKline Pharmaceuticals Limited

BSE:500660 Stock Report

Market Cap: ₹332.6b

GlaxoSmithKline Pharmaceuticals Future Growth

Future criteria checks 4/6

GlaxoSmithKline Pharmaceuticals is forecast to grow earnings and revenue by 21.1% and 8.5% per annum respectively. EPS is expected to grow by 19.4% per annum. Return on equity is forecast to be 40.7% in 3 years.

Key information

21.1%

Earnings growth rate

19.4%

EPS growth rate

Pharmaceuticals earnings growth18.6%
Revenue growth rate8.5%
Future return on equity40.7%
Analyst coverage

Low

Last updated23 Feb 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BSE:500660 - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202639,9538,6568,725N/A4
3/31/202536,4937,6787,018N/A4
3/31/202433,6496,0638,213N/A4
12/31/202333,1145,289N/AN/AN/A
9/30/202333,0846,4786,4496,890N/A
6/30/202332,6836,237N/AN/AN/A
3/31/202332,5176,0764,4024,842N/A
12/31/202232,7394,195N/AN/AN/A
9/30/202232,8753,9403,7864,133N/A
6/30/202233,0483,897N/AN/AN/A
3/31/202232,7803,8087,7618,107N/A
12/31/202134,8615,100N/AN/AN/A
9/30/202134,7084,9627,9128,354N/A
6/30/202133,4033,684N/AN/AN/A
3/31/202129,2562,8735,3375,779N/A
12/31/202031,6094,819N/AN/AN/A
9/30/202030,823-3,3583,8605,419N/A
6/30/202030,850905N/AN/AN/A
3/31/202032,2449323,3464,905N/A
12/31/201931,9941,019N/AN/AN/A
9/30/201932,4618,7682,8455,758N/A
6/30/201931,8044,749N/AN/AN/A
3/31/201931,2814,4541,1824,095N/A
3/31/201828,7153,5076944,728N/A
3/31/201729,0853,368N/A2,344N/A
3/31/201628,3793,761N/A1,389N/A
3/31/201526,3843,811N/A2,701N/A
12/31/201325,5974,817N/A2,813N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 500660's forecast earnings growth (21.1% per year) is above the savings rate (6.7%).

Earnings vs Market: 500660's earnings (21.1% per year) are forecast to grow faster than the Indian market (17.8% per year).

High Growth Earnings: 500660's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 500660's revenue (8.5% per year) is forecast to grow slower than the Indian market (10.5% per year).

High Growth Revenue: 500660's revenue (8.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 500660's Return on Equity is forecast to be very high in 3 years time (40.7%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.